M
Mehmet Akif Yesilipek
Researcher at Akdeniz University
Publications - 19
Citations - 251
Mehmet Akif Yesilipek is an academic researcher from Akdeniz University. The author has contributed to research in topics: Transplantation & Thalassemia. The author has an hindex of 7, co-authored 19 publications receiving 191 citations. Previous affiliations of Mehmet Akif Yesilipek include Bahçeşehir University & Medical Park.
Papers
More filters
Journal ArticleDOI
Successful haematopoietic stem cell transplantation in 44 children from healthy siblings conceived after preimplantation HLA matching
Semra Kahraman,C. Beyazyurek,Mehmet Akif Yesilipek,Gülyüz Öztürk,Mehmet Ertem,Sema Anak,Savaş Kansoy,Serap Aksoylar,Baris Kuskonmaz,Haldun Öniz,Shimon Slavin,Zeynep Karakas,H.A. Tac,N. Gulum,Gokhan Cumhur Ekmekci +14 more
TL;DR: Full recovery of 44 sick children who received HSCT from healthy infants conceived after pre-implantation HLA matching for the following 10 indications are reported; beta-thalassaemia, Wiskott-Aldrich syndrome, Fanconi anaemia, sickle cell anaemia), acute myeloid leukaemia, acute lymphoblastic leukaemi, Glanzmann's thrombasthaenia, Diamond-Blackfan anaemia and mucopolysaccharidosis type
Journal ArticleDOI
Hematopoetic stem cell transplantation in children
TL;DR: Brief information on stem cell sources, preparation therapies, HSCT indications and post-transplantation complications in children is given.
Journal ArticleDOI
Adverse COVID-19 outcomes in immune deficiencies: Inequality exists between subclasses.
Elif Karakoç Aydıner,Sevgi Bilgic Eltan,Royale Babayeva,Omer Aydiner,Eda Kepenekli,Burcu Kolukisa,Asena Pinar Sefer,Ezgi Yalcin Gungoren,Esra Karabiber,Esra Yücel,Öner Özdemir,Ayca Kiykim,Hasibe Artac,Nalan Yakıcı,Koray Yalcin,Haluk Cokugras,Tülin Tiraje Celkan,Fazil Orhan,Mehmet Akif Yesilipek,Safa Baris,Ahmet Ozen +20 more
TL;DR: In this article, the authors evaluated the outcome of SARS-CoV-2 infection among IEI subjects and analyzed genetic and immune characteristics that determine adverse COVID-19 outcomes.
Journal ArticleDOI
Peripheral blood stem cell transplantation in children with beta-thalassemia.
TL;DR: It is suggested that PSCT can be considered a safe and effective treatment for children with beta- thalassemia and transfusion-independent 2–30 months after PSCT.
Journal ArticleDOI
Peripheral stem cell transplantation in a child with amegakaryocytic thrombocytopenia.
TL;DR: A 13-month-old girl who was diagnosed as having congenital amegakaryocytic thrombocytopenia and was successfully treated with allogeneic peripheral stem cell transplantation (PSCT) from her fully matched sibling donor is presented.